The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Activation of retinoblastoma protein in mammary gland leads to ductal growth suppression, precocious differentiation, and adenocarcinoma
Open accessAbstract
The retinoblastoma (Rb) tumor suppressor controls cellular proliferation, survival, and differentiation and is functionally inactivated by mutations or hyperphosphorylation in most human cancers. Although activation of endogenous Rb is thought to provide an effective approach to suppress cell proliferation, long-term inhibition of apoptosis by active Rb may have detrimental consequences in vivo. To directly test these paradigms, we targeted phosphorylation-resistant constitutively active Rb alleles, RbΔKs, to the mouse mammary gland. Pubescent transgenic females displayed reduced ductal elongation and cell proliferation at the endbuds. Postpuberty transgenic mice exhibited precocious cellular differentiation and β-casein expression and extended survival of the mammary epithelium with a moderate but specific effect on the expression of E2F1, IGF1Rα, and phospho–protein kinase B/AKT. Remarkably, ∼30% RbΔK transgenic females developed focal hyperplastic nodules, and ∼7% exhibited full-blown mammary adenocarcinomas within 15 mo. Expression of the RbΔK transgene in these mammary tumors was reduced greatly. Our results suggest that transient activation of Rb induces cancer by extending cell survival and that the dual effects of Rb on cell proliferation and apoptosis impose an inherent caveat to the use of the Rb pathway for long-term cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The idea that RB could promote cancer under certain conditions by increasing survival is supported by experiments in transgenic mice expressing a phosphorylation-resistant, constitutively active allele of Rb in the mammary gland epithelium.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [86]
In the citing paper
“Strikingly, these transgenic mice develop focal hyperplastic lesions and mammary tumours, probably because the survival of differentiated mammary epithelial cells is extended after pregnancy86.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [86]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Proliferation, cell cycle and apoptosis in cancer
Evan, G. I., & Vousden, K. H. (2001) · Nature · doi:10.1038/35077213 · Cited by 2,724 · cited 1×
“However, as stated recently (Evan and Vousden, 2001) many growth deregulatory mutations have pleiotropic and tissue-specific effects on cell proliferation and apoptosis, and the therapeutic consequences of antiproliferative agents are thus difficult to predict.”
BackgroundThe regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317 · cited 3×
“…Rb in cell proliferation and apoptosis is well established, it is not clear whether Rb affects terminal differentiation directly through interaction with differentiation factors or indirectly by allowing proper cell cycle exit and cell survival (Dyson, 1998; Macleod, 1999; Harbour and Dean, 2000b).”
BackgroundInfluentialThe Pezcoller lecture: cancer cell cycles revisited.
Sherr, C. J. (2000) · PubMed · Cited by 1,408
McDonnell, T. J., Deane, N., Platt, F. M., Nunez, G., Jaeger, U., McKearn, J. P., & Korsmeyer, S. J. (1989) · Cell · doi:10.1016/0092-8674(89)90174-8 · Cited by 1,213 · cited 1×
“Similarly, a BCl2 transgene induces hyperplastic splenic follicles, which do not progress to B cell lymphoma in transgenic mice (McDonnell et al., 1989).”
BackgroundThe Rb/E2F pathway: expanding roles and emerging paradigms
Harbour, J. W., & Dean, D. C. (2000) · Genes & Development · doi:10.1101/gad.813200 · Cited by 1,153 · cited 3×
“Mechanisms of precocious differentiation in MMTV-Rb K transgenic mice Although the role of Rb in cell proliferation and apoptosis is well established, it is not clear whether Rb affects terminal differentiation directly through interaction with differentiation factors or indirectly by allowing proper cell cycle exit a…”
BackgroundLundberg, A. S., & Weinberg, R. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.753 · Cited by 1,067 · cited 4×
“Mitotic signals propagated through G1 cyclins induce sequential phosphorylation and inactivation of Rb (Lundberg and Weinberg, 1998).”
BackgroundInfluentialHarbour, J. W., Luo, R. X., Santi, A. D., Postigo, A. A., & Dean, D. C. (1999) · Cell · doi:10.1016/s0092-8674(00)81519-6 · Cited by 1,057 · cited 5×
“…to their resistance to phosphorylation by Cdks, the Rb Ks outperform wild-type Rb in multiple assays and are viewed as constitutively active, underphosphorylated, native Rb (Hamel et al., 1992; Geng et al., 1996; Knudsen et al., 1998; Sellers et al., 1998; Brown et al., 1999; Harbour et al., 1999).”
BackgroundInfluentialCyclin D1 provides a link between development and oncogenesis in the retina and breast
Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazeli, A., Gardner, H., Haslam, S. Z., Bronson, R. T., Elledge, S. J., & Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90034-9 · Cited by 1,021
Specific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934 · cited 2×
“In contrast to the MMTV/WAP-Rb K transgenic mice, cyclin D1–deficient mice do not succumb to mammary tumors but are rather protected from a subset of oncogenic pathways in the mammary gland (Sicinski et al., 1995; Yu et al., 2001b).”
BackgroundResult
Research works printed but not linked: 10
- 1993, Oncogene., 8, 2127
- 1996, Oncogene., 12, 1173
- 1998, Cell Growth Differ., 9, 229
- 2001, Cancer Res., 61, 8395
- 1992, Mol. Cell. Biol., 12, 3431
- 1993, Mol. Cell. Biol., 13, 6640
- 2001, Genes Dev., 15, 1833
- 2000, Cancer Res., 60, 3689
- 2001, Microsc. Res. Tech., 52, 155, 10.1002/1097-0029(20010115)52:2<155::aid-jemt1001>3.0.co;2-p · DOI · Paper page
- 1993, Mol. Cell. Biol., 13, 4588
Cited by
Cellular mechanisms of tumour suppression by the retinoblastoma gene
Burkhart, D. L., & Sage, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2399 · Cited by 974
“Strikingly, these transgenic mice develop focal hyperplastic lesions and mammary tumours, probably because the survival of differentiated mammary epithelial cells is extended after pregnanc”
BackgroundThe retinoblastoma tumour suppressor in development and cancer
Classon, M., & Harlow, E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc950 · Cited by 738
“Along these same lines, mice that express a 'hyperactive' Rb molecule (a mutated form of Rb that cannot be inactivated by phosphorylation) from the mouse mammary tumour virus (MMTV) promoter show reduced proliferation at the end buds, as well as precocious cellular differentiation and extended survival of the mammary…”
BackgroundCoordinated regulation of life and death by RB
Chau, B. N., & Wang, J. Y. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc993 · Cited by 292
“One-third of these mice developed hyperplastic nodules, and ∼7% of these mice developed adenocarcinoma”
BackgroundChinnam, M., & Goodrich, D. W. (2011) · Current Topics in Developmental Biology · doi:10.1016/b978-0-12-380916-2.00005-x · Cited by 199
“Consistent with this, constitutive activation of pRb in the mouse mammary gland initiates tumorigenesis (Jiang and Zacksenhaus, 2002).”
BackgroundThe retinoblastoma tumor-suppressor gene, the exception that proves the rule
Goodrich, D. W. (2006) · Oncogene · doi:10.1038/sj.onc.1209616 · Cited by 164
“This functional property predicts that pRb expression may be oncogenic, a prediction that has actually been verified under certain experimental conditions (Yamamoto et al., 1999; Jiang and Zacksenhaus, 2002; Borges et al., 2005).”
Background
Metadata
- Authors
- Jiang, Z., & Zacksenhaus, E.
- Affiliations
- University Health Network (CA)
- Corresponding author
- Zacksenhaus, Eldad
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2002-01-03
- Volume
- 156
- Issue
- 1
- Pages
- 185-198
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC2173568
- OpenAlex
- W2114749101
- Cited by
- 55
- References
- 83
- Citations by year
- 2025: 1 · 2023: 1 · 2022: 1 · 2020: 2 · 2019: 1 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 1 · 2012: 2
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Cell Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- TSpace (University of Toronto) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- retinoblastoma protein, mammary gland, mammary adenocarcinoma, apoptosis, cell proliferation, E2F1, IGF-1 receptor, Akt signaling, transgenic mice, tumor suppressor activation, cancer therapy
- MeSH terms
- Adenocarcinoma, Alleles, Animals, Breast, Cell Differentiation, Cell Division, Cell Survival, Female, Hyperplasia, Mammary Tumor Virus, Mouse, Mice, Transgenic, Milk Proteins, Models, Biological, Mutation, Parity, Phosphorylation, Pregnancy, RNA, Messenger, Mammary Neoplasms, Animal, Retinoblastoma Protein, In Situ Hybridization, Gene Expression Regulation, Developmental, Transgenes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Activation of retinoblastoma protein in mammary gland leads to ductal growth suppression, precocious differentiation, and adenocarcinoma. https://app.cochat.ai/papers/10.1083/jcb.200106084
- The paper
- Jiang, Z., & Zacksenhaus, E. (2002). Activation of retinoblastoma protein in mammary gland leads to ductal growth suppression, precocious differentiation, and adenocarcinoma. The Journal of Cell Biology. https://doi.org/10.1083/jcb.200106084
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.